Coldstream Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100	Closed	-$10.5K	–	2331
2025 Q1	$10.5K	Buy	+100	New	+$10.5K	﹤0.01%	2362
2018 Q4	–	Sell	-1,183	Closed	-$203K	–	356
2018 Q3	$203K	Buy	+1,183	New	+$203K	0.02%	355